Supplementary Figures S1-S4 from Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer

Supplementary Figure S1: Western blot densitometric quantifications. Supplementary Figure S2: FAK Inhibitor 14 (Inh14) and PF-562,271 (PF-271)'s effects on FAK expression/activity, cell proliferation, and apoptosis in NCI-H446 SCLC cell lines. Supplementary Figure S3: PF-573,228 (PF-228)'s effects on FAK expression/activity, cell proliferation, and apoptosis in NCI-H82 SCLC cell lines transduced with FAK shRNA. Supplementary Figure S4: phospho-Paxillin expression in NCI-H446 SCLC cell line where FAK has been inhibited with pharmacological and genetic methods.